Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
55M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
13.4M
-
Shares change
-
-712K
-
Total reported value, excl. options
-
$109M
-
Value change
-
-$6.75M
-
Put/Call ratio
-
0.11
-
Number of buys
-
31
-
Number of sells
-
-35
-
Price
-
$8.18
Significant Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) as of Q1 2023
79 filings reported holding AKYA - Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q1 2023.
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.4M shares
of 55M outstanding shares and own 24.3% of the company stock.
Largest 10 shareholders include Blue Water Life Science Advisors, LP (2.1M shares), Hudson Executive Capital LP (1.74M shares), Polar Capital Holdings Plc (1.32M shares), BlackRock Inc. (997K shares), VANGUARD GROUP INC (988K shares), Board of Trustees of The Leland Stanford Junior University (620K shares), Granahan Investment Management, LLC (597K shares), Altium Capital Management LP (500K shares), SVB WEALTH LLC (500K shares), and Uniplan Investment Counsel, Inc. (465K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.